InflaRx (IFRX) Return on Equity (2017 - 2026)

InflaRx has disclosed Return on Equity across 10 years of filings, most recently posting 469.22% for Q1 2026.

• Return on Equity for Q1 2026 came in at 469.22%, up 46922.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 469.22% (up 46922.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 469.22% for Q1 2026 at InflaRx, up from 423.66% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 469.22% in Q1 2026 to a low of 0.01% in Q3 2024.
• The 5-year median for Return on Equity is 14.22% (2022), against an average of 70.63%.
• Across the five-year window, Return on Equity tumbled 243053 bps in 2022 and surged 46922 bps in 2026, its largest moves.
• InflaRx's Return on Equity stood at 21.88% in 2022, then soared by 90 bps to 41.49% in 2023, then sank by 100 bps to 0.0% in 2024, then surged by 60320395 bps to 423.66% in 2025, then advanced by 11 bps to 469.22% in 2026.
• The last three Return on Equity figures came in at 469.22% (Q1 2026), 423.66% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.